DocGo Inc.

NASDAQ:DCGO

Medical - Care Facilities

Healthcare
$0.71 -4.29%

-$0.02 today

Market cap
$70.14M
Beta
1.00
P/E (TTM)
-0.3
EPS (TTM)
-$1.90
52W Low $0.49High $1.78

Volume 1.64M

Average 0.87M

DCGO Net Income

Bottom-line profit, the starting point for calculating cash from operations.

DocGo Inc.NASDAQ: DCGO

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income grows, but more slowly than its trailing trend

Q1 FY2026 net income of $16.7T (cash outflow) rose 150729973.2% year over year, behind the +200670695.8% change in trailing-twelve-month net income. Sequentially, it rose 11732207.6% from the prior quarter.

Context

  • Net income amounted to 60.9% of revenue in FY2025, up 57.7 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 4 analysts of -$32.75M (-83.3%) for the fiscal year ending Dec 2026, a step up from the -1082.2% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$16.7T+11732207.6% QoQ
Last fiscal yearDec 2025
-$196.37M-1082.2% YoY
LTMMar 2026
-$16.7T+200670695.8% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+150729973.2%-27.6%-150730000.8 pp
1 year-1082.2%-83.3%+998.9 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(196.37M) USD
Year-over-year change
-1082.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How DCGO compares with its peers on the latest reported figures

  • DCGO's LTM Mar 2026 net income of $16.7T is the largest of the 9 companies compared; the peer median is $31.03M.
  • Its year-over-year change of +200670695.8% is the highest of 9, against a peer median of +17.9%.
  • Net income amounts to 5535061.0% of revenue for DCGO, versus a peer median of 302.7%.
DCGO Competitors Peer median
Net Income for DCGO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DCGODocGo Inc.LTM Mar 2026$16.7T +200670695.8%—5535061.0%
PRLDPrelude Therapeutics IncorporatedLTM Mar 2026$77.8M -39.1%-4.8%465.3%
MGNXMacroGenics, Inc.LTM Mar 2026$70.36M +26.1%-14.6%44.8%
RCELAVITA Medical, Inc.LTM Mar 2026$45.34M -20.5%+22.1%62.7%
IMMXImmix Biopharma, Inc.LTM Mar 2026$34.98M +67.3%+52.9%—
VANIVivani Medical, Inc.LTM Mar 2026$27.09M +14.1%+24.2%—
OVIDOvid Therapeutics Inc.LTM Mar 2026$24.17M -3.2%-31.5%339.3%
COYACoya Therapeutics, Inc.LTM Mar 2026$21.13M +23.3%+20.1%266.1%
MBOTMicrobot Medical Inc.LTM Mar 2026$14.21M +21.8%-0.1%13535.2%
Peer median (excluding DCGO) $31.03M+17.9%+10.0%302.7%

Competitors are the stored peer set for DCGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income19.18M30.74M6.86M19.99M(196.37M)
Depreciation & Amortization7.07M10.57M16.43M15.88M15.66M
Deferred Income Tax(630.38K)(9.96M)(1.98M)3.47M7.75M
Stock-Based Compensation1.38M8.05M20.97M13.63M17.44M
Change in Working Capital(28.8M)(13.18M)(113.12M)19.52M81.66M
Accounts Receivables(58M)(8.42M)(160.52M)41.27M112.5M
Inventory00000
Accounts Payables11.88M3.64M(1.78M)8.56M(17.64M)
Other Working Capital17.31M(8.4M)49.18M(30.32M)(13.19M)
Other Non-Cash Items(142.67K)2.64M6.62M(2.16M)108.31M
Operating Cash Flow(1.95M)28.87M(64.22M)70.34M34.45M
Capital Expenditures(6.66M)(5.5M)(10.13M)(5.84M)(7.43M)
Acquisitions (Net)(1.96M)(32.95M)(19.46M)(310.45K)(16.4M)
Purchases of Investments(655.88K)00(5M)0
Sales of Investments655.88K00013.16M
Other Investing Activities(1.82M)(2.3M)(2.84M)(1.73M)(31.3M)
Investing Cash Flow(8.59M)(38.45M)(29.88M)(10.87M)(39.08M)
Debt Repayment(2.82M)(3.94M)20.7M613.55K(35.17M)
Common Stock Issued178.1M01.58M00
Common Stock Repurchased(479.33K)(3.73M)0(13.76M)(10.83M)
Dividends Paid000(1.29T)0
Other Financing Activities(19.6M)1.49M(21.17M)1.29T(4.82M)
Financing Cash Flow155.21M(6.18M)1.12M(24.15M)(50.82M)
Effect of Forex Changes(21.41K)761.23K1.09M(190.64K)595.8K
Net Change in Cash144.65M(15M)(91.89M)35.12M(54.85M)
Free Cash Flow(8.6M)23.37M(74.35M)64.5M27.02M

DocGo Inc.

NASDAQ:DCGO

Intrinsic Alpha fair value

Locked

Current Price

$0.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.